Hospital Rurality and Gene Expression Profiling for Early-Stage Breast Cancer among Iowa Residents (2010–2018)

<div>GEP testing trends among women with early-stage, HR+, HER2−, LN− breast cancer by hospital location. GEP, gene expression profiling; HER2−, human epidermal growth factor receptor 2 negative; HR+, hormone receptor-positive; LN−, lymph node negative.</div>

The Breast Journal

fig2

Figure 2

Figure 2: Hospital Rurality and Gene Expression Profiling for Early-Stage Breast Cancer among Iowa Residents (2010–2018) 